yeah - I watched for all that time but I see you on many biotech threads and you know the sector sentiment is completely different now - people are hunting for a sniff of a biotech with a story and a SP that hasn't doubled or tripled so PYC will behave quite differently 'if' they have something to tell.
The phylomer library contains so much potential that it could triple just on people noticing it. The share register is pretty tight now - the 2 puking fund managers are gone and the largest shareholder tried to get through the 20% rule in a cheeky underwritten rights issue.
I understand your caution and this could simply do nothing but the conditions are ripe for significant re-rating and all the company needs to do is give a reason.
yeah - I watched for all that time but I see you on many biotech...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
-0.075(5.28%) |
Mkt cap ! $784.4M | |||
| Open | High | Low | Value | Volume |
| $1.42 | $1.42 | $1.34 | $742.4K | 546.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 12580 | $1.33 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.35 | 1436 | 2 |
View Market Depth
| Last trade - 15.57pm 23/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |